TABLE 1

Characteristics of the recipients and living donors at baseline

VariableRecipientsLiving donorsp-value#
Number of patients n3535
Indications for lung transplantation
 Interstitial lung disease21 (60%)
 Lung injury after haematopoietic stem cell transplantation9 (26%)
 Idiopathic pulmonary artery hypertension2 (6%)
 Bronchiectasis2 (6%)
 Idiopathic pulmonary hemosiderosis1 (3%)
Smoking history (+)15 (43%)13 (37%)0.63
mMRC score 0/1/2/3/4 n0/0/0/16/1933/2/0/0/0<0.001
Female19 (54%)19 (54%)1
Age years46.8±13.2 (18–63)45.1±10.9 (21–60)0.50
Height m1.60±0.09 (1.28–1.72)1.63±0.06 (1.52–1.77)0.11
Weight kg48.0±10.8 (30.4–72.9)60.9±9.4 (45.5–78.8)<0.001
BMI kg·m−218.5±3.3 (12.2–25.2)22.6±2.8 (17.8–29.6)<0.001
Albumin g·dL−13.6±0.6 (2.0–5.0)4.3±0.3 (3.7–5.2)<0.001
VC % predicted44.6±17.2 (16.9–88.0)108.9±17.8 (85.1–169.8)<0.001
FEV1/FVC %77.2±23.8 (21.1–100.0)82.5±5.5 (70.8–92.8)0.21
FEV1 % predicted38.9±19.0 (15.0–86.6)104.4±13.6 (81.6–131.8)<0.001
DLCO % predicted24.1±14.5 (7.3–63.2)+92.7±10.3 (75.3–114.8)<0.001
6MWD m209.0±104.3 (19.0–380.0)585.2±86.4 (400.0–736.0)ƒ<0.001
ESMCSA cm223.0±7.2 (11.3–39.9)30.5±6.9 (19.7–45.8)<0.001
ESMCT HU45.4±9.8 (13.8–59.8)46.6±7.2 (30.9–57.6)0.56
Quadriceps force Nm·kg-12.11±0.71 (0.82–3.48)§
Procedure of LDLLT
 Single/double LTx n2/33
 Right/left lower lobectomy n18/17
Predicted postoperative VC % predicted61.6±15.1 (40.3–104.8)

Data are presented as n (%) or mean±sd (range), unless otherwise stated. mMRC: modified Medical Research Council; BMI: body mass index; VC: vital capacity; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; DLCO: diffusing capacity of the lung for carbon monoxide; 6MWD: 6-min walk distance; ESMCSA: cross-sectional area of the erector spinae muscles; ESMCT: mean computed tomography values of the erector spinae muscles. #: Chi-squared test or t-test; : number of valid observations, 27; +: number of valid observations, 14; §: number of valid observations, 26; ƒ: number of valid observations, 33.